Applications of N,N'-Dimethyloxalamide in Industrial Manufacturing

As a chemical raw material manufacturer, we supply N,N'-Dimethyloxalamide for use in specialized chemical processes by downstream industries. This compound supports multiple segments in fine chemicals, agrochemicals, pharmaceuticals, polymer additives, and organic synthesis. Below are descriptions of its primary applications, including compliance requirements, recommended dosing, process integration, and forms of end-use products.

1. Organic Synthesis Intermediate for Heterocyclic Compounds

Our clients in fine chemicals utilize N,N'-Dimethyloxalamide as a C2 synthon in the synthesis of isoxazole and pyrazole derivatives. It assists in achieving selective amide formation under controlled temperature and pressure in batch or continuous reactors. The purity and controlled moisture content align with strict intermediate production protocols. End users value the material for its stable reactivity profile, which reduces side-product formation in heterocycle-building reactions.

Industry compliance standards

• REACH Regulation (EC) No 1907/2006 for import and use within the EU
• ISO 9001:2015 for chemical manufacturing processes
• Good Manufacturing Practice (GMP, ICH Q7) when used in pharmaceutical intermediates
• Auditable supply chain traceability for EU and US downstream registrants

Typical usage ratio

• 0.8 to 1.1 mole equivalents relative to nucleophilic partners; adjusted to optimize conversion and minimize waste

Downstream process integration

• Charged during initial batch charging in multi-step synthesis lines, following rigorous in-process QC to verify purity and water content
• Often dissolved in polar aprotic solvents for reactivity control and selectivity

Final product types

• Heterocyclic building blocks (e.g., isoxazoles, pyrazoles)
• Custom fine chemical intermediates
• Functionalized aryl-oxalamide derivatives for specialty synthesis

2. Precursor for Agrochemical Active Ingredient Development

Formulators and agrochemical manufacturers use N,N'-Dimethyloxalamide for the synthesis of active ingredients in crop protection agents. The compound serves as a condensation source to build amide and amidine functionalities, integral for developing new herbicide or insecticide scaffolds. Stringent monitoring ensures compliance with regional pesticide regulations and product registration schemes.

Industry compliance standards

• FAO/WHO Joint Meeting on Pesticide Specifications (JMPS)
• ISO 17025 for testing laboratories
• Regulation (EC) No 1107/2009 concerning the placement of plant protection products on the market (Europe)
• US EPA Pesticide Registration standards (40 CFR Parts 150-180)

Typical usage ratio

• 5–20 wt% as a synthesis intermediate in multi-step routes; determined by crop-specific active ingredient target yield and impurity profile

Downstream process integration

• Introduced during core active ingredient assembly, often in condensation or cyclization reactors
• Monitored via HPLC or GC to ensure residuals stay below regulatory thresholds

Final product types

• Agrochemical actives: amide-based herbicides, fungicides, and insecticides
• Custom plant protection intermediates
• Pre-formulated bulk pesticides for toll formulation

3. Intermediate for Pharmaceutical Fine Chemical Synthesis

Pharmaceutical contract manufacturers and API producers incorporate N,N'-Dimethyloxalamide as an intermediate in the synthesis of specialty active pharmaceutical ingredients (APIs) or their precursors. The compound’s low residual solvent and stable handling properties support compliance with global pharmacopeial and quality frameworks. Specific product documentation and cleaning validation are applied in dedicated synthesis suites to avoid trace cross-contamination.

Industry compliance standards

• United States Pharmacopeia (USP) standards for API starting materials
• European Pharmacopoeia (Ph. Eur.) monographs (where relevant)
• ICH Q7 Good Manufacturing Practice Guide for Active Pharmaceutical Ingredients
• FDA 21 CFR Part 211 (CGMP for finished pharmaceuticals, where applicable)

Typical usage ratio

• 1.0 equiv to 1.2 equiv with respect to partnering amines for convergent route synthesis; optimized per product specification and validation protocol

Downstream process integration

• Added at designated intermediate forming reaction steps in GMP-compliant synthesis trains
• Subject to in-process analytical control and batch release testing for trace impurities

Final product types

• Active pharmaceutical ingredient (API) intermediates used in contract and in-house synthesis
• Speciality drug precursor compounds for further functionalization
• R&D batches for generic and proprietary drug development pipelines

4. Additive in Polymer Processing and Modification

Polymer compounders and plastics manufacturers apply N,N'-Dimethyloxalamide as a chain extender and crystallinity modifier in polyamide and specialty resin formulations. Its high melting point and solubility make it suitable for compounding under elevated temperatures, with minimal impact on polymer melt dynamics. Strict lot tracking and thermal property assessment are maintained for compounding consistency and end-use product reliability.

Industry compliance standards

• ISO 9001:2015 polymer compounding operations
• REACH Annex XVII (restrictions on chemicals in polymers for EU marketing)
• RoHS Directive 2011/65/EU for electrical/electronic plastics (where relevant)
• UL Yellow Card program for flame-retardant additives and plastic components (if downstream products require)

Typical usage ratio

• 0.1–1.5 phr (per hundred resin) for polyamide blends; level adjusted for crystallinity and mechanical property targets

Downstream process integration

• Dry blended with other resin additives before extrusion or injection molding
• Dosed directly into twin-screw extruder hopper for in-line compounding

Final product types

• Polyamide-based engineering plastics
• Modified thermoplastic masterbatches
• Precision-molded components for automotive and electronics industries